The Sigma-1 Receptor Antagonist, S1RA, Reduces Stroke Damage, Ameliorates Post-Stroke Neurological Deficits and Suppresses the Overexpression of MMP-9
Crossref DOI link: https://doi.org/10.1007/s12035-017-0697-x
Published Online: 2017-08-05
Published Print: 2018-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Sánchez-Blázquez, Pilar http://orcid.org/0000-0002-7211-4504
Pozo-Rodrigálvarez, Andrea
Merlos, Manuel
Garzón, Javier
Funding for this research was provided by:
Secretaría de Estado de Investigación, Desarrollo e Innovación (SAF-2015-65420R)
License valid from 2017-08-05